JW Lifescience Corporation

KSE 234080.KS

JW Lifescience Corporation Shares (Diluted, Weighted) for the year ending December 31, 2023: 15,484,554

JW Lifescience Corporation Shares (Diluted, Weighted) is 15,484,554 for the year ending December 31, 2023, a 0.00% change year over year. Shares (diluted, weighted) are the number of outstanding shares used to calculate earnings per share (EPS) assuming the conversion of all potentially dilutive securities.

JW Lifescience Corporation Shares (Diluted, Weighted) for the year ending December 31, 2022 was 15,484,554, a -0.61% change year over year.
JW Lifescience Corporation Shares (Diluted, Weighted) for the year ending December 31, 2021 was 15,580,304, a -1.61% change year over year.
JW Lifescience Corporation Shares (Diluted, Weighted) for the year ending December 31, 2020 was 15,834,554, a 0.00% change year over year.
JW Lifescience Corporation Shares (Diluted, Weighted) for the year ending December 31, 2019 was 15,834,554, a -0.01% change year over year.

Key data

Date	Shares (Diluted, Weighted)	Revenue	Cost of Revenue	Gross Profit

KSE: 234080.KS

JW Lifescience Corporation

CEO	Sungnam Cha
IPO Date	Oct. 27, 2016
Location	South Korea
Headquarters	28, Hanjin 1-gil
Employees	301
Sector	Consumers Staples
Industries Non-Alcoholic Beverages Baby & Childcare Biotechnology Frozen Foods Personal Care Pet Food Pharmaceuticals Soft Drinks & Sodas

Description

JW Lifescience Corporation engages in the development, production, and sale of infusion solutions in South Korea and internationally. It offers basic intravenous fluid that comprises water, electrolytes, and glucose; nutrient infusion solution that consist of nutrients, such as amino acids, lipids, proteins, vitamins, and minerals; and special infusion solutions. The company was formerly known as JW Co. Ltd. and changed its name to JW Lifescience Corporation in April 2011. JW Lifescience Corporation was founded in 1994 and is based in Dangjin, South Korea.

Key trends

Past 5 years